Michael J.  Sena net worth and biography

Michael Sena Biography and Net Worth

CFO of INNOVATE
Michael J. Sena serves as Chief Financial Officer of the Company. Sena has been HC2’s Chief Financial Officer since June 2015 and is a director and/or officer of several of HC2’s subsidiaries. Prior to joining the Company, Mr. Sena was the Senior Vice President and Chief Accounting Officer of HRG from October 2014 to June 2015, and had previously served as the Vice President and Chief Accounting Officer, from November 2012 to October 2014. Mr. Sena was also the Vice President and Chief Accounting Officer of Zap.Com, a subsidiary of HRG, from November 2012 to June 2015, and served as a director of Zap.Com from December 2014 until June 2015. From January 2009 until November 2012, Mr. Sena held various accounting and financial reporting positions with Reader’s Digest Association, Inc., last serving as Vice President and North American Controller. Before joining Reader’s Digest Association, Inc., Mr. Sena served as Director of Reporting and Business Processes for Barr Pharmaceuticals from July 2007 until January 2009. Prior to that, Mr. Sena held various positions with PricewaterhouseCoopers, LLP. Mr. Sena is a Certified Public Accountant and holds a Bachelor of Science in Accounting from Syracuse University.

What is Michael J. Sena's net worth?

The estimated net worth of Michael J. Sena is at least $685,804.60 as of March 14th, 2024. Mr. Sena owns 1,078,818 shares of INNOVATE stock worth more than $685,805 as of May 1st. This net worth approximation does not reflect any other assets that Mr. Sena may own. Learn More about Michael J. Sena's net worth.

How do I contact Michael J. Sena?

The corporate mailing address for Mr. Sena and other INNOVATE executives is 450 PARK AVENUE 30TH FLOOR, NEW YORK NY, 10022. INNOVATE can also be reached via phone at (212) 235-2690 and via email at [email protected]. Learn More on Michael J. Sena's contact information.

Has Michael J. Sena been buying or selling shares of INNOVATE?

Michael J. Sena has not been actively trading shares of INNOVATE in the last ninety days. Most recently, Michael J. Sena sold 16,555 shares of the business's stock in a transaction on Tuesday, March 16th. The shares were sold at an average price of $3.55, for a transaction totalling $58,770.25. Following the completion of the sale, the chief financial officer now directly owns 591,765 shares of the company's stock, valued at $2,100,765.75. Learn More on Michael J. Sena's trading history.

Who are INNOVATE's active insiders?

INNOVATE's insider roster includes Wayne Barr, Jr. (CEO), Avram Glazer (Director), and Michael Sena (CFO). Learn More on INNOVATE's active insiders.

Michael J. Sena Insider Trading History at INNOVATE

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/16/2021Sell16,555$3.55$58,770.25591,765View SEC Filing Icon  
11/23/2020Sell91,291$2.40$219,098.40614,553View SEC Filing Icon  
3/15/2019Buy9,600$2.61$25,056.00403,702View SEC Filing Icon  
11/14/2016Buy10,000$4.55$45,500.00163,194View SEC Filing Icon  
See Full Table

Michael J. Sena Buying and Selling Activity at INNOVATE

This chart shows Michael J Sena's buying and selling at INNOVATE by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

INNOVATE Company Overview

INNOVATE logo
INNOVATE Corp. engages in the acquisition and investment of assets. It operates through the following segments: Infrastructure, Clean Energy, Telecommunications, Insurance, Life Sciences, Spectrum, and Other. The Infrastructure segment models, details, fabricates, and erects structural steel for commercial and industrial construction projects. The Clean Energy segment designs, builds, and maintains compressed natural gas fueling stations for transportation vehicles. The Telecommunications segment manages telecommunications business including a network of direct routes and provides voice communication services. The Insurance segment offers long-termcare, life, annuity, and other accident and health coverage. The Life Sciences segment maintains controlling interests in Genovel Orthopedics, Inc. and R2 Technologies, Inc. through Pansend Life Sciences LLC. The Spectrum segment owns over-the-air broadcasting stations and spanish-language broadcast network. The Other segment represents all other businesses or investments that do not meet the definition of a segment individually or in the aggregate. The company was founded in 1994 and is headquartered in New York, NY.
Read More

Today's Range

Now: $0.64
Low: $0.55
High: $0.64

50 Day Range

MA: $3.77
Low: $3.45
High: $4.25

2 Week Range

Now: $0.64
Low: $2.06
High: $4.75

Volume

233,791 shs

Average Volume

437,553 shs

Market Capitalization

$49.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.31